Source: Pharmacy Times articles
As the cell and gene therapy pipeline expands, experts at Asembia’s AXS25 Summit emphasized the need for error-proof logistics, value-based access strategies, and coordinated reimbursement models.
Read More
by MM360 Staff | Apr 30, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
As the cell and gene therapy pipeline expands, experts at Asembia’s AXS25 Summit emphasized the need for error-proof logistics, value-based access strategies, and coordinated reimbursement models.
Read More